Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  rilimogene-galvacirepvec
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Enzalutamide with or without Vaccine Therapy in Treating Patients with Metastatic Hormone Resistant Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13-C-0146, NCI-2013-01565, 1301-1204, 130146, P121106, RD-13-I-11, NCT01867333
Enzalutamide with or without Vaccine Therapy in Treating Patients with Non-metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13-C-0153, NCI-2013-01570, 1301-1205, 130153, P121105, RD-13-I-12, NCT01875250
Vaccine Therapy in Treating Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0112, NCI-2014-02498, 1401-1286, P131384, RD-14-I-08, NCT02153918
Rilimogene-Galvacirepvec in Preventing Disease Progression in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: Not specified
Trial IDs: 1410547210, NCI-2014-02556, AZ027, HHSN2612012000311, N01-CN-2012-00031, UAZ2014-03-01, NCT02326805
Start Over